Compositions for treating spinal muscular atrophy Grant US-11938136-B2 United States of America 26 Mar 2024
Heterocyclic and heteroaryl compounds for treating Huntington's disease Grant US-11858941-B2 United States of America 02 Jan 2024
Compounds for treating Huntington's disease Grant US-11780839-B2 United States of America 10 Oct 2023
Heteroaryl compounds for treating Huntington's disease Grant US-11685746-B2 United States of America 27 Jun 2023
Compounds for treating Huntington's disease Grant US-11407753-B2 United States of America 09 Aug 2022
IMIDAZO[1,2-A]PYRAZIN-1-YL-BENZAMIDES FOR TREATING SPINAL MUSCULAR ATROPHY Application RU-2725979-C2 Russian Federation 08 Jul 2020
Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof Grant US-9988626-B2 United States of America 05 Jun 2018
Substituted imidazo[1,2-α]pyrazines for treating spinal muscular atrophy Grant US-9975900-B2 United States of America 22 May 2018
IMIDAZO[1,2-A]PYRAZIN-1YL-BENZAMIDE COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY Application WO-2015197503-A1 World Intellectual Property Organisation (WIPO) 30 Dec 2015
Compounds for the inhibition of histone deacetylase Application US-8008344-B2 United States of America 30 Aug 2011
Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase Grant US-7994357-B2 United States of America 09 Aug 2011